Changeflow GovPing Pharma & Drug Safety Heterocycle Amino Acid Compound and Complex Patent
Routine Notice Added Final

Heterocycle Amino Acid Compound and Complex Patent

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Organic Chemistry (C07D)
Published March 11th, 2026
Detected March 26th, 2026
Email

Summary

The European Patent Office has published patent application EP4501909A1 concerning a heterocycle-containing amino acid compound and complex. The patent application was filed by Aichi Steel Corporation and Tokushima University and lists MERA Akane, SUZUKI Motofumi, and NAMBA Kosuke as inventors. The publication date is March 11, 2026.

What changed

The European Patent Office (EPO) has published a new patent application, EP4501909A1, related to a heterocycle-containing amino acid compound and its complex. This publication signifies the formal disclosure of the invention by the applicants, Aichi Steel Corporation and Tokushima University, and lists MERA Akane, SUZUKI Motofumi, and NAMBA Kosuke as the inventors. The patent application falls under various International Patent Classification (IPC) codes, including C07D (Heterocyclic compounds) and C07F (Organometallic compounds).

This is a routine patent publication and does not impose immediate compliance obligations on regulated entities. However, companies operating in the pharmaceutical and biotechnology sectors, particularly those involved in the research and development of novel compounds, should be aware of this disclosure. It may impact future patent strategies, freedom-to-operate analyses, and competitive intelligence efforts within the organic chemistry and drug development fields.

Source document (simplified)

← EPO Patent Bulletin

HETEROCYCLE-CONTAINING AMINO ACID COMPOUND AND COMPLEX

Publication EP4501909A1 Kind: A1 Mar 11, 2026

Applicants

Aichi Steel Corporation, Tokushima University

Inventors

MERA Akane, SUZUKI Motofumi, NAMBA Kosuke

IPC Classifications

C07D 207/16 20060101AFI20260203BHEP C07F 15/02 20060101ALI20260203BHEP A01N 43/36 20060101ALI20260203BHEP A01N 55/02 20060101ALI20260203BHEP C07D 205/04 20060101ALI20260203BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Classification

Agency
EPO
Published
March 11th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP4501909A1

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 3254.1 Biotechnology
Activity scope
Drug Development Patent Filing
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Biotechnology

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Organic Chemistry (C07D) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.